Key points are not available for this paper at this time.
Canadian physicians and their patients are all too familiar with prescription drug shortages. The production stoppage in 2012 at the facility that produces most of the generic injectable drugs in Canada became a major issue for the health care system and showed the supply chain’s vulnerability.
Rawson et al. (Sun,) studied this question.